Implications of discontinuation of doxazosin arm of ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
- PMID: 10752699
- DOI: 10.1016/s0140-6736(00)00092-1
Implications of discontinuation of doxazosin arm of ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
Erratum in
- Lancet 2000 Apr 8;355(9211):1280
Comment in
-
Discontinuation of doxazosin arm of ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack.Lancet. 2000 Apr 29;355(9214):1558. doi: 10.1016/s0140-6736(05)74613-4. Lancet. 2000. PMID: 10801204 No abstract available.
-
First-line antihypertensive therapy.Lancet. 2000 Aug 5;356(9228):508-9. doi: 10.1016/S0140-6736(05)74179-9. Lancet. 2000. PMID: 10981915 No abstract available.
-
First-line antihypertensive therapy. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension.Lancet. 2000 Aug 5;356(9228):509. doi: 10.1016/s0140-6736(05)74181-7. Lancet. 2000. PMID: 10981916 No abstract available.
-
First-line antihypertensive therapy.Lancet. 2000 Aug 5;356(9228):509-10. doi: 10.1016/S0140-6736(05)74182-9. Lancet. 2000. PMID: 10981917 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical